Abivax S.A. (ABVX) stock

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30

$90.20−1.24 (-1.36%)

Close on Nov 12, 2026Market cap $7.08BP/E –Yield –

Abivax total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?